Research & Innovation

Clinical Trials

Clinical Trials

INARI MEDICAL- PEERLESS_RCT

Physician & Study Coordinator

Physician

Ellen Redstone, MD

Study Coordinators

Danielle Schneider
Danielle.Schneider@sluhn.org

Close

Synopsis

FlowTriever System versus Catheter-Directed Thrombolysis (CDT) for use in the treatment of acute pulmonary embolism (PE).

Close

Eligibility Criteria

Subjects must meet each of the following criteria to be included in the study:

  1. Age ≥ 18 years
  2. Echo, computed tomographic pulmonary angiography (CTPA), or pulmonary angiographic evidence of any proximal filling defect in at least one main or lobar pulmonary artery. Clinical signs and symptoms consistent with acute PE, or PESI class III-V, or sPESI ≥1
  3. Intervention planned to begin within 72 hours of the later of either
  4. Confirmed PE diagnosis
  5. Symptom onset within 14 days of confirmed PE diagnosis

Close